Local doctor breaks down J&J nerve condition concerns

The FDA updates the label on Johnson-and-Johnson's COVID vaccine to warn about an increased risk of a rare neurological condition. Dr. Todd Ellerin, chief of infectious diseases at South Shore Health, discusses the condition called Guillain-Barré syndrome and what the science shows.